Evidence map›Paper›PMID 41857375›Full record

ArticleGenes and immunity2026

Increased VH4+JH6+ antibody heavy chain use in plasmablasts from asymptomatic multiple sclerosis patients.

Sara Benavides, Scott Christley, Kiel M Telesford, Chad Smith, Katelyn Sheffer, Yipin Wu, Wei Zhang, Key M Tse, Hannah J Greenberg, Morgan Jackson and 10 more

Abstract read
In one paragraph

Article in Genes and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sara Benavides *Department of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.ORCID 0009-0004-4344-9681
Scott Christley *School of Public Health, UT Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-9889-1221
Kiel M TelesfordDepartment of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.
Chad SmithDepartment of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.
Katelyn ShefferDepartment of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.
Yipin WuDepartment of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.
Wei ZhangDepartment of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.
Key M TseDepartment of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.
Hannah J GreenbergDepartment of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.
Morgan JacksonDepartment of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.ORCID 0009-0008-4183-1747
Caitlin ChapmanDepartment of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.
Darina DinovDepartment of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.
Paula HardemanDepartment of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.
Aksel SivaDepartment of Neurology, Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey.
Daniel PelletierNeuroRX Research, Montreal, QC, Canada.
Orhun KantarciNeurology, Mayo Clinic, Rochester, MN, USA.
Christine Lebrun-FrénayNeurology MS Clinic Nice, Pasteur 2 University Hospital; UR2CA-URRIS, Côte d'Azur University, Nice, France.
Lindsay G CowellSchool of Public Health, UT Southwestern Medical Center, Dallas, TX, USA.
Darin T OkudaDepartment of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.
Nancy L MonsonDepartment of Neurology, UT Southwestern Medical Center, Dallas, TX, USA. nancy.monson@utsouthwestern.edu.ORCID 0000-0002-7175-7700

Funding

Contribution of plasmablasts in the conversion of transverse myelitis to multiple sclerosisR01NS102417 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI MONSON, NANCY L · 2018 to 2022
$2.8M
Ethnicity-Associated, Differential CNS Demyelinating Autoimmune Disease Severity: Reconciling Identity, Ancestry and Neurotoxic Antibody ResponseK22NS123508 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Kiel Telesford · 2021 to 2026
$626k
Immune Profiling of EncephalitisR21NS098229 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI MONSON, NANCY L, VENKATESAN, ARUN · 2016 to 2017
$461k
High-performance slide scanner for multichannel fluorescence, brightfield and polarizationS10OD032267 · OD · UT SOUTHWESTERN MEDICAL CENTER · PI RAMIREZ, DENISE MARIE · 2022 to 2022
$208k
NIH HHS S10 OD032267NINDS NIH HHS K22 NS123508NINDS NIH HHS R01 NS102417NINDS NIH HHS R21 NS098229
6 · The paper itself

Abstract

Radiologically isolated syndrome (RIS) is a neurological condition in people with demyelinating lesions on brain and/or spinal cord magnetic resonance imaging (MRI) studies, but without clinical symptoms of disease. Elucidating the immune profile of people with RIS (pwRIS) who will display MRI or clinical features of advancing disease is critical to our understanding of disease pathogenesis. Our lab previously identified features of B cell dysregulation in people with clinically isolated syndrome (pwCIS), who have both demyelinating lesions and a first clinical event of disease. The goal of this study was to compare features of B cell dysregulation in pwRIS, pwCIS, and healthy controls (HC). The second goal was to determine if these features of B cell dysregulation would be evident in people who meet the new MS diagnostic criteria, particularly in the context of their disease course for 5 years post-sampling. Features of plasmablast responses that distinguish pwRIS from pwCIS include PB expansion, antigen-driven selection, VH4 and JH6 antibody gene over-usage, neuron reactivity by purified IgG and individually cloned antibodies. Furthermore, VH4:JH6 pairing in plasmablasts was higher in people with stable MS who do not show changes in MRI or clinical events from those with advancing disease activity.

Indexed as

Immunoglobulin Heavy ChainsImmunoglobulin Variable RegionMultiple SclerosisPlasma CellsAdultFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedImmunoglobulin Heavy ChainsImmunoglobulin Variable Region

Identifiers

PMID41857375
PMCPMC13241311

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.